Picture of Bioharvest Sciences logo

8MV0 Bioharvest Sciences News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Bioharvest Sciences Inc expected to post a loss of 11 cents a share - Earnings Preview

Bioharvest Sciences Inc 8MV0.MU  is expected to  report resultson August 11 for the period ending June 30 2025

The Vancouver British Columbia-based  company is expected to report revenue of $8.533 million, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Bioharvest Sciences Inc is for a loss of 11 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Bioharvest Sciences Inc is $14.50, about 44.1% above its last closing price of $8.10

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.13-0.12-0.13Missed-8.3
Dec. 31 2025-0.12-0.12-0.17Missed-37.8
​​
This summary was machine generated August 8 at 15:16 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Bioharvest Sciences

See all news